News
Investors are worried how the company will handle the 2028 expiration of the U.S. patents protecting Keytruda, Merck’s ...
Therini Bio, Inc., a clinical-stage biotech company developing fibrin-targeting immunotherapies for neurodegenerative diseases driven by vascular dysfunction today announced that the first patient has ...
The program was formally launched July 28 at a signing ceremony at Wake Tech’s Beltline Education Center in Raleigh. Leaders ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
The market value of the company surpassed the size of Denmark’s entire economy last year and, for a period, Novo Nordisk was ...
Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they ...
Lilly’s appeal of an earlier, negative recommendation from a key EMA committee has worked out in its favor, and puts the drug ...
Commonly used sulfonylureas were associated with an up to 13% increase in risk for major adverse CV events vs.
4d
Zacks Investment Research on MSNHow Will Eli Lilly's Oncology Drugs Perform in Q2 Earnings?Eli Lilly LLY offers a diverse range of products that serve multiple therapeutic areas. While the company’s primary focus is ...
Longer treatment duration, not having diabetes, and using semaglutide are among the factors linked to better weight reduction over 12 months.
Donald Trump has a lot of thoughts. Most of them don't make any sense, and the sentences themselves are often barely ...
Alberto Conca, CIO at Swiss wealth manager LFG+ZEST, has been adding exposure to pharma, biotech and medtech in recent weeks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results